From autonomic failure to Parkinson’s and beyond: tracking the early warning signs of synuclein related disease. Phenoconversion means the transition from one clinical condition to another over time, in this case from pure autonomic failure to disorders like Parkinson’s disease, dementia with Lewy bodies or multiple system atrophy. Virameteekul and colleagues describe in a new paper in JAMA Neurology how frequently and under what conditions folks w/ pure autonomic failure develop central α-synucleinopathies. Key points: - Approximately 30% of individuals w/ pure autonomic failure developed a central α-synucleinopathy over follow-up, w/ an annual conversion rate of about 5%. - Multiple system atrophy tended to emerge earlier, while Parkinson’s disease and dementia with Lewy bodies showed a more gradual and sustained risk over time. - Clinical features such as REM sleep behavior disorder, subtle motor signs and hyposmia (smell loss) were among the most consistent predictors of conversion. My take: This study reinforces something many of us have suspected for years: the autonomic nervous system may be one of the earliest windows into neurodegeneration. The ability to identify who is at highest risk and when conversion may occur could reshape how we think about early diagnosis and intervention. Here are 5 points that resonated w/ me: 1- Autonomic symptoms may represent an early stage of Parkinson’s biology rather than a separate condition. 2- A 5% annual conversion rate is meaningful and highlights the need for close longitudinal follow-up. 3- Timing matters as different diseases emerge on different trajectories. 4- Simple clinical features like smell loss and dream enactment may help stratify risk today. 5- The future will likely combine clinical signs w/ biomarkers to identify the right folks for early intervention and disease modifying trials. cutt.ly/DtXwCc8u @JAMANetwork @jamaneuro @ParkinsonDotOrg #parkinson